In brief: SR One beats target for sophomore biotech fund
Fund II's limited partners include endowments, foundations, pharmaceutical companies, pension funds, sovereign wealth funds, and family offices.
28 March 2023•1 min read
Fund II's limited partners include endowments, foundations, pharmaceutical companies, pension funds, sovereign wealth funds, and family offices.
Inovia hits $200m in first close for sixth early-stage fund
19 October 2026 · 4 mins read
Meet venture capital’s 2026 Women of Influence
5 October 2026 · 4 mins read
Eyeing opportunities and how the Women of Influence see trends developing
5 October 2026 · 3 mins read
Oura IPO to ring up big payday for Finnish VC Lifeline
25 September 2026 · 3 mins read
US LPs are warming to Europe: Brighteye's Ben Wirz
22 September 2026 · 7 mins read
Bain Capital Ventures closes on $1.6bn for Fund XI, targeting AI infrastructure and more
17 September 2026 · 3 mins read
Volition Capital closes on $950m for oversubscribed Fund VI
16 September 2026 · 4 mins read
